Up-regulation of eukaryotic elongation factor-1 subunits in breast carcinoma

Anticancer Res. 2005 May-Jun;25(3c):2573-7.

Abstract

Background: Wide evidence suggests the involvement of translation elongation factors (EFs) at the onset of oncogenesis. To investigate the potential role of the EF-1 subunits (A, Balpha and Bgamma) in the formation and progression of breast cancer, we quantified their expression in human breast tissues and cell lines.

Materials and methods: The mRNA levels of EF-1A, -1Balpha and -1Bgamma in human breast tissues and cell lines were measured by semi-quantitative RT-PCR and Northern blotting, respectively.

Results: The mRNA expression of the three EF-1 subunits was significantly higher in cancerous over normal tissues. However, there was no significant difference in their expression between tumor grades. Overexpression of EF-1 mRNA in breast cancer cell lines were not caused by increased mRNA stability.

Conclusion: Although not indicative of tumor grading, the elevated levels of EF-1 subunits are suggestive of their early role in the pathogenesis of breast cancer, possibly through their increased rate of transcription.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / genetics
  • Breast Neoplasms / metabolism*
  • Cell Line, Tumor
  • Eukaryotic Initiation Factor-1 / biosynthesis*
  • Eukaryotic Initiation Factor-1 / genetics
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Protein Subunits
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Up-Regulation

Substances

  • Eukaryotic Initiation Factor-1
  • Protein Subunits
  • RNA, Messenger